Loading...
OctoPlus signs drug development contract with The Medicines Company
13-Jul-2010
- Netherlands
Advertisement
OctoPlus N.V. announced that it has signed a pharmaceutical development and manufacturing contract with a new client, US-based The Medicines Company. The undisclosed contract value will make a material contribution to OctoPlus' annual revenues.
Under the contract terms, OctoPlus will perform process development and clinical manufacturing for The Medicines Company related to MDCO-216 (ApoA-I Milano/phospholipid complex).